WuXi AppTec Inc. announced that it has entered into partnership with QIAGEN to provide an integrated single solution for molecular biomarker development. The laboratory will be located at WuXi AppTec's campus in Shanghai and will begin operating immediately.
Pursuant to deal, QIAGEN will provide a complete portfolio of instrumentation, training, and consumables and WuXi AppTec will provide laboratory facilities and staff to execute the services.
Under the terms of deal, WuXi AppTec will also work with QIAGEN to help develop biomarkers, assay panels, personalized healthcare diagnostics, and other products that QIAGEN intends to bring to market. WuXi AppTec and QIAGEN will also co-promote each other's services to their respective customers.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.